UNITED THERAPEUTICS Corp (UTHR)

Pharmaceutical Preparations

Latest Price

$517.71

TTM P/E

19.14

Normalized P/E

24.86

Div Yield

Book Value

135.66

P/B Ratio

3.82

Valuation metrics

EPS: $27.86

Book value / share: $162.60

Formula: √(22.5 × EPS × BVPS)

Graham Number

$319.25

38% downside

Norm. op. income: $980M (median of 7yr)

Tax rate: 22%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$241.48

53% downside

Base FCF: $748M (median of recent 5yr)

Growth: 13%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$582.10

+12% upside

EPS: $27.86

Target P/E: 25×

Formula: EPS × P/E

P/E Fair Value

$696.50

+35% upside

100.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	5.40M	$3.20B	12.81%	+228.9K	2026-03-31
Avoro Capital Advisors LLC	3.01M	$1.57B	7.14%	+403.9K	2026-03-31
WELLINGTON MANAGEMENT GROUP LLP	2.26M	$1.34B	5.37%	-177.2K	2026-03-31
VANGUARD PORTFOLIO MANAGEMENT LLC	2.00M	$1.19B	4.75%	--	2026-03-31
VANGUARD CAPITAL MANAGEMENT LLC	1.96M	$1.16B	4.64%	--	2026-03-31
STATE STREET CORP	1.84M	$1.09B	4.37%	+1.6K	2026-03-31
RENAISSANCE TECHNOLOGIES LLC	1.79M	$1.06B	4.24%	-122.2K	2026-03-31
GEODE CAPITAL MANAGEMENT, LLC	1.23M	$729.0M	2.92%	+40.0K	2026-03-31
Caption Management, LLC	1.15M	$682.0M	2.73%	+714.0K	2026-03-31
JANUS HENDERSON GROUP PLC	866.9K	$514.0M	2.06%	+70.8K	2026-03-31